IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential

• Dorit Lehmann ,

  Contributed equally to this work with: Dorit Lehmann, Jan Spanholtz

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯
• Jan Spanholtz ,

  Contributed equally to this work with: Dorit Lehmann, Jan Spanholtz

  Affiliation Glycostem Therapeutics, s-Hertogenbosch, Nijmegen, The Netherlands

  ⨯
• Caterina Sturtzel,

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯
• Marleen Tordoir,

  Affiliation Glycostem Therapeutics, s-Hertogenbosch, Nijmegen, The Netherlands

  ⨯
• Bernhard Schlechta,

  Affiliation Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria

  ⨯
• Dirk Groenewegen,

  Affiliation Glycostem Therapeutics, s-Hertogenbosch, Nijmegen, The Netherlands

  ⨯
• Erhard Hofer

  * E-mail: erhard.hofer@meduniwien.ac.at

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯